STAAR Surgical Co (STAA) stock
STAANasdaqOphthalmic GoodsFiscal year ends January 2
$26.39−0.39 (-1.46%)
Close on Nov 13, 2026Market cap $1.32BP/E –Yield –
STAAR Surgical r&d expenses
Research and development expenses are spending on new products and technology.
STAAR Surgical's R&D Expenses for the twelve months ending Oct 2, 2026 was $39.57M, down 2.5% year over year. For fiscal 2025 it was $40.06M, down 11.6% from the year before. Over ten years it grew 10.5% a year on average. The highest annual figure on record is $45.32M in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | $40.06M | -11.6% |
| FY2024 | Dec 27, 2024 | $45.32M | +12.0% |
| FY2023 | Dec 29, 2023 | $40.48M | +12.5% |
| FY2022 | Dec 30, 2022 | $35.98M | +6.3% |
| FY2021 | Dec 31, 2021 | $33.86M | +6.1% |
| FY2020 | Jan 1, 2021 | $31.92M | +26.2% |
| FY2019 | Jan 3, 2020 | $25.30M | +14.8% |
| FY2018 | Dec 28, 2018 | $22.03M | +9.9% |
| FY2017 | Dec 29, 2017 | $20.04M | -3.0% |
| FY2016 | Dec 30, 2016 | $20.67M | +40.0% |
| FY2015 | Jan 1, 2016 | $14.76M | +19.4% |
| FY2014 | Jan 2, 2015 | $12.36M | +84.3% |
| FY2013 | Jan 3, 2014 | $6.71M | +4.1% |
| FY2012 | Dec 28, 2012 | $6.44M | +9.8% |
| FY2011 | Dec 30, 2011 | $5.87M | +2.5% |
| FY2010 | Dec 31, 2010 | $5.72M | -2.9% |
| FY2009 | Jan 1, 2010 | $5.89M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Oct 2, 2026 | $10.46M | +13.6% |
| Q2 FY2026 | Jul 3, 2026 | $9.94M | -3.1% |
| Q1 FY2026 | Apr 3, 2026 | $9.93M | -12.5% |
| Q4 FY2025 | Jan 2, 2026 | $9.24M | -5.4% |
| Q3 FY2025 | Sep 26, 2025 | $9.21M | -24.8% |
| Q2 FY2025 | Jun 27, 2025 | $10.26M | -13.5% |
| Q1 FY2025 | Mar 28, 2025 | $11.34M | -15.3% |
| Q4 FY2024 | Dec 27, 2024 | $9.77M | +40.7% |
| Q3 FY2024 | Sep 27, 2024 | $12.25M | +6.8% |
| Q2 FY2024 | Jun 28, 2024 | $11.87M | +1.0% |
| Q1 FY2024 | Mar 29, 2024 | $13.38M | +29.8% |
| Q4 FY2023 | Dec 29, 2023 | $6.94M | -29.1% |
| Q3 FY2023 | Sep 29, 2023 | $11.47M | +19.3% |
| Q2 FY2023 | Jun 30, 2023 | $11.76M | +36.1% |
| Q1 FY2023 | Mar 31, 2023 | $10.31M | +29.8% |
| Q4 FY2022 | Dec 30, 2022 | $9.79M | +7.9% |
| Q3 FY2022 | Sep 30, 2022 | $9.62M | +16.3% |
| Q2 FY2022 | Jul 1, 2022 | $8.64M | +4.6% |
| Q1 FY2022 | Apr 1, 2022 | $7.94M | -3.9% |
| Q4 FY2021 | Dec 31, 2021 | $9.07M | +1.3% |
| Q3 FY2021 | Oct 1, 2021 | $8.27M | -5.5% |
| Q2 FY2021 | Jul 2, 2021 | $8.26M | +13.0% |
| Q1 FY2021 | Apr 2, 2021 | $8.26M | +19.7% |
| Q4 FY2020 | Jan 1, 2021 | $8.96M | +20.9% |
| Q3 FY2020 | Oct 2, 2020 | $8.75M | +42.2% |
| Q2 FY2020 | Jul 3, 2020 | $7.31M | +19.9% |
| Q1 FY2020 | Apr 3, 2020 | $6.90M | +22.4% |
| Q4 FY2019 | Jan 3, 2020 | $7.41M | +29.9% |
| Q3 FY2019 | Sep 27, 2019 | $6.16M | +10.5% |
| Q2 FY2019 | Jun 28, 2019 | $6.10M | +14.1% |
| Q1 FY2019 | Mar 29, 2019 | $5.64M | +4.2% |
| Q4 FY2018 | Dec 28, 2018 | $5.71M | +1.4% |
| Q3 FY2018 | Sep 28, 2018 | $5.57M | +21.2% |
| Q2 FY2018 | Jun 29, 2018 | $5.35M | +12.1% |
| Q1 FY2018 | Mar 30, 2018 | $5.41M | +13.0% |
| Q4 FY2017 | Dec 29, 2017 | $5.63M | +21.0% |
| Q3 FY2017 | Sep 29, 2017 | $4.59M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.77M | – |
| Q1 FY2017 | Mar 31, 2017 | $4.78M | – |
| Q4 FY2016 | Dec 30, 2016 | $4.65M | – |
See a number that looks wrong?